Clinical Trial Update: A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 SAD/MAD study in healthy Chinese participants evaluating safety, tolerability, and pharmacokinetics of RO7049389.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO7049389

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B Virus | Phase 1 | Status: COMPLETED | Results posted: 2020-02-28